PreMarket Price
PreMarket Price
Constellation Brands, Inc. (STZ) logo

Stock Analysis

Constellation Brands, Inc.STZ

Price:$131.35Market Closed+1.37%at last close

P/E 11.66×· 5Y range 10.60–483.43×· bottom 3% of history

Sector: Consumer Defensive · Industry: Beverages

AnalystsBuy29 analysts
Mkt Cap 22.18BP/E 11.6Div Yield 3.23%ROE 25.0%
Low 10.6×11.7×High 483.4×

P/E 11.7× sits at the 3rd percentile of its 5.086926762491444-year history.

Cash $0.15BNet debt $10.51BDebt $10.66B

Cash covers 1% of debt · Q3 2026.

Profilev90g26p82h53q81m50

PMP Verdict

Mixed fundamentals, cheap valuation

Strengths

  • Profitability82
  • Quality81

Risks

  • Growth26
Revenue +0.9% CAGRP/E 12× · 3rd pctl

Mixed business trading cheap — priced for skepticism.

Bull Case

  • ✓Piotroski F-Score 7/9 — high earnings quality
  • ✓ROE 25.0% — efficient capital deployment
  • ✓P/E 11.7× at bottom 3% of 5-year history

What's happening with STZ

Last big move: +4.4% on 2026-10-08

Profile

Valuation — 90/100 (Strong) P/E vs own history: 3th pct → 25/25 FCF yield: 8.3% → 25/25 P/S: 2.4x → 20/25 EV/EBIT: 11.7x → 20/25Valuation90Growth — 26/100 (Weak) Revenue CAGR: 0.9% → 6/25 Net income CAGR: n/a → 0/25 EPS CAGR 5Y: n/a → 0/25 Fwd implied growth: 19.3% → 20/25Growth26Profitability — 82/100 (Strong) ROIC: 12.1% → 12/25 ROE: 25.0% → 20/25 Net margin: 20.9% → 25/25 Operating margin: 30.2% → 25/25Profitability82Financial Health — 53/100 (Moderate) Altman Z: 2.61 → 18/25 Current ratio: 1.34 → 12/25 Interest coverage: 7.9x → 18/25 Net cash / debt: D/A 48% → 5/25Health53Quality — 81/100 (Strong) Piotroski F: 7/9 → 22/25 Beneish M: -7.66 → 25/25 FCF conversion: 96% → 22/25 Margin stability: σ 8.5% → 12/25Quality81Moat — 50/100 (Moderate) ROIC >12% years: 2/9 yrs → 0/25 Median gross margin: 50.4% → 20/25 FCF-positive years: 10/10 yrs → 25/25 Worst-year net margin: worst -0.8% → 5/25Moat50

Strong valuation, profitability and earnings quality; growth lags behind.

How is each axis scored?
  • Valuation90/100 · Strong
    • P/E vs own history (3th pct)25/25
    • FCF yield (8.3%)25/25
    • P/S (2.4x)20/25
    • EV/EBIT (11.7x)20/25
  • Growth26/100 · Weak
    • Revenue CAGR (0.9%)6/25
    • Net income CAGR (n/a)0/25
    • EPS CAGR 5Y (n/a)0/25
    • Fwd implied growth (19.3%)20/25
  • Profitability82/100 · Strong
    • ROIC (12.1%)12/25
    • ROE (25.0%)20/25
    • Net margin (20.9%)25/25
    • Operating margin (30.2%)25/25
  • Financial Health53/100 · Moderate
    • Altman Z (2.61)18/25
    • Current ratio (1.34)12/25
    • Interest coverage (7.9x)18/25
    • Net cash / debt (D/A 48%)5/25
  • Quality81/100 · Strong
    • Piotroski F (7/9)22/25
    • Beneish M (-7.66)25/25
    • FCF conversion (96%)22/25
    • Margin stability (σ 8.5%)12/25
  • Moat50/100 · Moderate
    • ROIC >12% years (2/9 yrs)0/25
    • Median gross margin (50.4%)20/25
    • FCF-positive years (10/10 yrs)25/25
    • Worst-year net margin (worst -0.8%)5/25

Risk Flags

  • ⚠4 loss-making years in recent history

About Constellation Brands, Inc.

Constellation Brands is the largest provider of alcoholic beverages across the beer, wine, and spirits categories in the US, generating more than 90% of revenue from Mexican beer imports under top-selling brands such as Modelo and Corona. Show more

The rest of the business includes some remaining wine and spirits brands, categories where the company has pruned assets in recent years. With its exclusive rights tied to the Mexican beer brands effective only in the US, the firm has limited revenue exposure to international markets. Constellation owns a 10% stake in Canopy Growth, a medicinal and recreational cannabis producer in Canada, and has a 50/50 joint venture with glass manufacturer Owens-Illinois in Mexico.

Headquarters: ROCHESTER, NY · Employees: 9,400 · Website ↗

Price History

Weekly Candlestick Chart — up to 5Y

Key Metrics

Financial snapshot · Tap any metric for its definition and grade

TTM Snapshot

trailing twelve months · YoY
Revenue
9.2B-4%
Op. Income
2.8B+25%
Net Income
1.9B+57%
EPS
11.2+62%
Operating CF
2.7B-4%
Free CF
1.8B-0%

Valuation

90A+
P/E (TTM)11.6xA

Grade A: CheapPrice / TTM EPS (own statements) — vs own 5Y history: 10.6x–483.4x · 3rd pct

P/FCF11.9xA

Grade A: CheapPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative

FCF Yield8.3%A

Grade A: ValueTTM (OCF − CapEx) / Market Cap — vs own 5Y history: 2.9%–9.5% · 97th pct

P/S (TTM)2.41xB

Grade B: FairPrice / TTM Revenue (own statements) — vs own 5Y history: 2.1x–5.6x · 4th pct

EV/EBIT11.7xA

Grade A: CheapEnterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 5Y history: 10.3x–327.2x · 7th pct

EV/Sales3.5xB

Grade B: FairEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple

Forward P/E9.7xA

Grade A: CheapPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth

P/B Ratio2.88xA

Grade A: FairPrice to Book Value. Neg. equity = heavy buybacks

PEG Ratio3.85D

Grade D: ExpensiveFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)

Dividend Yield3.23%A

Grade A: PaysTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress

Payout Ratio36.8%A

Grade A: SafeDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable

P/E vs own 5Y historyBelow average · 3rd pct

Profitability

82A
ROIC12.1%C

Grade C: AverageNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat

ROE25.0%A

Grade A: StrongReturn on Equity. Neg. equity = heavy buybacks

ROA8.8%C

Grade C: AverageReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit

Net Margin20.9%A

Grade A: HighNet Income / Revenue

Operating Margin30.2%A

Grade A: HighTTM EBIT / TTM Revenue

Gross Margin52.7%A

Grade A: PremiumGross Profit / Revenue

FCF Margin20.0%A

Grade A: HighFCF / Revenue

True FCF Margin19.2%A

Grade A: HighTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost

Growth

26E
Revenue CAGR0.9%D

Grade D: LowCompound annual revenue growth (up to 5Y depending on data availability)

Net Income CAGR—

Compound annual net income growth (up to 5Y depending on data availability)

EPS CAGR (5Y)—

Compound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0

Implied EPS Growth19.3%C

Grade C: MedAnalyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth

Dilution (5Y)-11.2%A

Grade A: BuybacksShare count change over 5Y

SBC / Net Income3.7%A

Grade A: LowStock-based comp/Net income. >30% = dilution risk

SBC / Revenue0.8%A

Grade A: LowTTM stock-based comp / TTM Revenue

Financial Health

53C
Altman Z-Score2.61C

Grade C: Gray zoneBankruptcy risk. >3 Safe, <1.8 Distress

Current Ratio1.34xC

Grade C: OkCurrent Assets/Liabilities

Quick Ratio0.26xD

Grade D: Low(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory

Interest Coverage7.9xC

Grade C: OkEBIT/Interest. >10 Strong

Debt Repayment5.7yC

Grade C: AverageYears to repay net debt via FCF

Net Debt/EBIT3.8xC

Grade C: MedLeverage. <2x Low, >4x High

Debt/Equity1.38xC

Grade C: MedDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.

Cash / Debt0.01xD

Grade D: ThinCash covers how much of total debt. >1 = could repay all debt from cash

Quality

81A
Piotroski F-Score7/9A

Grade A: StrongFinancial strength 0–9. >7 Strong

Beneish M-Score-7.66A

Grade A: SafeEarnings manipulation risk. < -2.22 Safe

FCF Conversion95.6%A

Grade A: StrongFCF / Net Income

Margin Stability8.5%C

Grade C: AverageEBIT margin std deviation. Lower = stable

Capex / Revenue8.9%C

Grade C: AverageTTM CapEx / TTM Revenue — high % = capital-hungry business

Asset Turnover0.42xD

Grade D: LowRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales

4/10 Loss Years

Insider Transactions

SEC Form 4 · 8 records
Open-market · 90dBuy —Sell —Other filings 11No open-market trades

P/S codes are the directional signal; grants, option exercises and tax withholding carry none. Form 4 doesn't flag 10b5-1 plans — scheduled sales may appear within open-market sells.

Recent insider transactions
Trade dateTransactionShares
Flatley Edith Morgan
Filed
Grant / award
+1.4K
Madero Garza Jose Manuel
Filed
Grant / award
+1.4K
Clark Christy
Filed
Grant / award
+1.4K
Zaramella Luca
Filed
Grant / award
+1.4K
Hernandez Ernesto M
Filed
Grant / award
+1.4K
Show 3 more filings
Additional recent insider transactions
Trade dateTransactionShares
Daniels Jennifer
Filed
Grant / award
+1.4K
Baldwin Christopher J
Filed
Grant / award
+1.4K
SANDS ROBERT
Filed
Grant / award
+1.4K
More metrics — Moat, Per Share, Balance Sheet, Market

Moat

50C
ROIC >12% Years2/9 yrsD

Grade D: WeakShare of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability

Gross Margin (Med.)50.4%A

Grade A: DurableMedian annual gross margin across available fiscal years — pricing-power durability

FCF-Positive Years10/10 yrsA

Grade A: DurableShare of completed fiscal years with positive free cash flow

Net Margin Floor-0.8%D

Grade D: WeakWeakest annual net margin across completed fiscal years — recession/downcycle resilience

Per Share

EPS (TTM)$11.27

Own TTM net income / shares — same earnings basis as P/E

Cash / Share$0.58

Cash & short-term investments per share (Finnhub)

Book Value / Share$50.57

Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks

Balance Sheet

Total Debt$10.66B

Total debt obligations (short + long term)

Cash & Equiv.$152.40M

Cash and short-term investments

Net Debt$10.51B

Total Debt minus Cash. Negative = Net Cash position

Total Equity$7.71B

Shareholders' equity (book value)

Asset / Liability1.58xC

Grade C: AdequateTotal Assets / Total Liabilities

Market

Market Cap$22.18B

Current Market Capitalization

Beta0.44B

Grade B: DefensivePrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings

How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.

Financials as of Aug 2026 · Ratio snapshot Oct 17, 2026

Key Insights: Constellation Brands, Inc. (STZ)

STZ is up 1.37% at the last close. Constellation Brands, Inc. meets 7 of 9 Piotroski F-Score criteria, placing its fundamental strength in the top tier of US-listed stocks. Altman Z-Score of 2.61 falls in the grey zone (1.81–2.99) — financial distress is unlikely but not ruled out. Beneish M-Score of -7.66 suggests a low likelihood of earnings manipulation. Constellation Brands, Inc. converts about 20% of revenue into free cash flow — strong cash generation.

  • Takes ~5.7 years to repay net debt from free cash flow.
  • Constellation Brands, Inc. posted a net loss in 4 of 10 available completed fiscal years (2017–2026).
  • At a valuation score of 90/100, STZ trades near the cheapest end of its own historical range (P/E 11.6).
  • Return on equity of 25.0% is well above the market average.
  • The stock currently yields 3.2% in dividends.

See how STZ ranks on the Capex Tracker — top 50 capital spenders compared.

Recent Earnings Results

DateTimeEPS Est.EPS ActualSurpriseRev Est.Rev Actual
Oct 6, 2026After-Hrs$3.60$3.74
+3.8%
$2.6B$2.6B

Recent Market Moves

See all STZ moves →
DateSessionPriceMoveZ-Score
Oct 8Regular123.62+4.41%3.58
Oct 8After-hours123.49+4.31%3.50
Oct 7Regular118.54+2.48%2.22
Oct 6After-hours110.36-2.60%-2.08

Frequently Asked Questions about STZ

What is the current Constellation Brands, Inc. (STZ) stock price?

STZ is trading at $131.35 at the last market close, up 1.37% on the session. PreMarketPrice tracks STZ pre-market, intraday and after-hours prices.

Is STZ stock a buy right now?

PreMarketPrice's quantitative model rates Constellation Brands, Inc.'s financial health at 53/100. This is a data-driven snapshot of fundamentals, not investment advice.

Is STZ stock overvalued?

Constellation Brands, Inc. trades at a trailing P/E of 11.6 and our valuation score rates it 90/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.

When does Constellation Brands, Inc. report earnings?

No confirmed earnings date is currently scheduled for STZ. The Earnings section lists recent reports and updates as dates are announced.

What sector does Constellation Brands, Inc. operate in?

Constellation Brands, Inc. operates in the Consumer Defensive sector, within the Beverages industry. The Related Stocks section lists sector peers for comparison.

What does Constellation Brands, Inc. do?

Constellation Brands is the largest provider of alcoholic beverages across the beer, wine, and spirits categories in the US, generating more than 90% of revenue from Mexican beer imports under top-selling brands such as Modelo and Corona.

About Constellation Brands, Inc. (STZ) Stock

Constellation Brands, Inc. (STZ) is a US-listed stock operating in the Consumer Defensive sector, specifically the Beverages industry. As of the latest update, Constellation Brands, Inc. is trading at $131.35, up 1.37% on the day with a market capitalization of $22.2 billion. The financial health score for STZ is 53/100, which indicates moderate financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for STZ stock.

STZ Stock Analysis & Key Metrics

On PreMarketPrice, you can track Constellation Brands, Inc. (STZ) across multiple dimensions:

Is STZ a Good Stock to Buy?

This page provides data-driven analysis to help you evaluate Constellation Brands, Inc. (STZ) as an investment. The financial health score of 53/100 suggests moderate financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average. Earnings data reveals whether the company is meeting or beating analyst expectations.However, this is not financial advice — always do your own research before investing.

Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Constellation Brands, Inc. (STZ) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.

Related opportunities

Moving today in Consumer Defensive
More Beverages stocks
Cheaper alternatives
Similar fundamentals